Dr. Stephen C Young , MD
Internal Medicine - Endocrinology, Diabetes & Metabolism โข Midlothian, VA
348 Brown's Hill Ct
Midlothian, VA 23114
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Stephen Young is listed in NPPES under Internal Medicine - Endocrinology, Diabetes & Metabolism.
-
NPI assigned on February 9, 2006; this date does not establish years in practice.
-
Published CMS data list 4,574 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 โ Established patient outpatient office visit: 2,005 service units.
- G0439 โ Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit: 495 service units.
- G2211 โ Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 444 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 16 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 12,989 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Rosuvastatin Calcium โ 893 prescription fills, including refills.
- Levothyroxine Sodium โ 660 prescription fills, including refills.
- Atorvastatin Calcium โ 560 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 165 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 70% of clinicians listed under Internal Medicine - Endocrinology, Diabetes & Metabolism in Midlothian, VA (2024, 15 clinicians with data). Median for this group: 5,714. Middle half: 2,771 to 8,999.
More Medicare Part B services than 85% of clinicians listed under Internal Medicine - Endocrinology, Diabetes & Metabolism in Virginia (2024, 183 clinicians with data). Median for this group: 838. Middle half: 431 to 1,959.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 3,854 in 2020 to 4,574 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
348 Brown's Hill Ct
Midlothian, VA 23114
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 2 distinct group names: Professional Therapies Of Roanoke, Inc.; Virginia Diabetes And Endocrinology Pc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Virginia Commonwealth University, School Of Medicine
1987
What Public CMS Data Show
Internal Medicine - Endocrinology, Diabetes & Metabolism: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
740 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $410,463 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $314,218 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
31,757 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,875,587 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,323.04 across 69 records.
By nature of payment
- Food and Beverage: $1,323.04 across 69 records.
Reporting-company totals (3 largest of 21)
- Novo Nordisk Inc: $375.41 across 23 records.
- Amgen Inc.: $154.09 across 11 records.
- Insulet Corporation: $108.13 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
39 years (graduated 1987)
CMS Doctors and Clinicians data list 1987 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Young has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Young as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Midlothian and Virginia
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 70% of clinicians listed under Internal Medicine - Endocrinology, Diabetes & Metabolism in Midlothian, VA (2024, 15 clinicians with data). Median for this group: 5,714. Middle half: 2,771 to 8,999.
More Medicare Part B services than 85% of clinicians listed under Internal Medicine - Endocrinology, Diabetes & Metabolism in Virginia (2024, 183 clinicians with data). Median for this group: 838. Middle half: 431 to 1,959.
Medicare-allowed amount
A higher Medicare-allowed amount than 75% of clinicians listed under Internal Medicine - Endocrinology, Diabetes & Metabolism in Midlothian, VA (2024, 15 clinicians with data). Median for this group: $229,324. Middle half: $121,823 to $379,212.
A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine - Endocrinology, Diabetes & Metabolism in Virginia (2024, 183 clinicians with data). Median for this group: $66,392. Middle half: $33,552 to $141,048.
Paid by Medicare
A higher Medicare payment amount than 75% of clinicians listed under Internal Medicine - Endocrinology, Diabetes & Metabolism in Midlothian, VA (2024, 15 clinicians with data). Median for this group: $183,423. Middle half: $91,603 to $285,185.
A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine - Endocrinology, Diabetes & Metabolism in Virginia (2024, 183 clinicians with data). Median for this group: $48,169. Middle half: $25,399 to $102,912.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Internal Medicine - Endocrinology, Diabetes & Metabolism in Midlothian, VA (2024, 16 clinicians with data). Median for this group: 2,741. Middle half: 1,656 to 3,736.
More Part D prescriptions than 95% of clinicians listed under Internal Medicine - Endocrinology, Diabetes & Metabolism in Virginia (2024, 200 clinicians with data). Median for this group: 1,624. Middle half: 588 to 2,993.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Internal Medicine - Endocrinology, Diabetes & Metabolism in Midlothian, VA (2024, 16 clinicians with data). Median for this group: $1,007,659. Middle half: $719,770 to $1,468,119.
A higher Part D drug cost than 85% of clinicians listed under Internal Medicine - Endocrinology, Diabetes & Metabolism in Virginia (2024, 200 clinicians with data). Median for this group: $775,157. Middle half: $293,409 to $1,287,279.
17 active clinicians are listed under Internal Medicine - Endocrinology, Diabetes & Metabolism with a practice address in Midlothian, VA (268 in Virginia).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Midlothian
82.4% of these 17 clinicians have the CMS telehealth indicator.
82.4% of these 17 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 19% from 3,854 in 2020 to 4,574 in 2024.
- 2020: 3,854
- 2021: 3,902
- 2022: 4,239
- 2023: 4,297
- 2024: 4,574
-
Medicare-allowed amount
Medicare-allowed amount increased 14% from $359,281 in 2020 to $410,463 in 2024.
- 2020: $359,281
- 2021: $402,556
- 2022: $418,933
- 2023: $422,281
- 2024: $410,463
-
Paid by Medicare
Paid by Medicare increased 21% from $259,381 in 2020 to $314,218 in 2024.
- 2020: $259,381
- 2021: $303,204
- 2022: $311,170
- 2023: $320,754
- 2024: $314,218
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 22% from 10,689 in 2020 to 12,989 in 2024.
- 2020: 10,689
- 2021: 11,148
- 2022: 11,632
- 2023: 11,729
- 2024: 12,989
-
30-day fills
30-day fills increased 26% from 25,158 in 2020 to 31,757 in 2024.
- 2020: 25,158
- 2021: 26,974
- 2022: 28,410
- 2023: 28,724
- 2024: 31,757
-
Part D drug cost
Part D drug cost increased 42% from $1,319,058 in 2020 to $1,875,587 in 2024.
- 2020: $1,319,058
- 2021: $1,408,396
- 2022: $1,766,549
- 2023: $2,026,154
- 2024: $1,875,587
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $364.88 in 2021 to $1,323.04 in 2025.
- 2021: $364.88
- 2022: $774.91
- 2023: $861.17
- 2024: $1,193.84
- 2025: $1,323.04
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 69 records totaling $1,323.04.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Insulet Corporation |
Food and Beverage
Cash or cash equivalent
|
Omnipod | General | $108.13 |
| CeQur Corporation |
Food and Beverage
Cash or cash equivalent
|
CeQur Simplicity | General | $38.94 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $34.17 |
| Sequel Med Tech, LLC |
Food and Beverage
In-kind items and services
|
TWIIST | General | $25.62 |
| Madrigal Pharmaceuticals |
Food and Beverage
In-kind items and services
|
REZDIFFRA | General | $25.16 |
| Xeris Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
RECORLEV | General | $24.78 |
| Abbott Laboratories |
Food and Beverage
In-kind items and services
|
FREESTYLE LIBRE 3 | General | $24.69 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
TEPEZZA | General | $24.17 |
| Xeris Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
GVOKE HYPOPEN | General | $24.16 |
| Abbott Laboratories |
Food and Beverage
In-kind items and services
|
FREESTYLE LIBRE 3 | General | $23.80 |
| Tandem Diabetes Care, Inc. |
Food and Beverage
In-kind items and services
|
t:slim X2 Insulin Pump with Control-IQ | General | $23.08 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $22.88 |
| Mannkind Corporation |
Food and Beverage
In-kind items and services
|
AFREZZA | General | $22.12 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
NURTEC ODT | General | $22.07 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $21.46 |
| Sequel Med Tech, LLC |
Food and Beverage
In-kind items and services
|
TWIIST | General | $20.71 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $20.59 |
| Amgen Inc. |
Food and Beverage
In-kind items and services
|
EVENITY | General | $20.20 |
| Soleno Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
VYKAT XR | General | $19.76 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Rybelsus | General | $19.76 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
NURTEC ODT | General | $19.70 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $19.63 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $19.41 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $19.13 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $18.84 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
2,005 | 710 | $145.00 | $124.06 |
|
G0439
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
|
495 | 495 | $138.00 | $125.33 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
444 | 323 | $25.45 | $15.82 |
|
G0444
Annual depression screening, 5 to 15 minutes
|
410 | 410 | $20.00 | $18.28 |
|
G0446
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes
|
405 | 405 | $30.00 | $24.36 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
206 | 158 | $100.00 | $87.76 |
|
95251
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report
|
176 | 78 | $65.00 | $33.09 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
147 | 116 | $224.00 | $174.33 |
|
82962
Blood glucose (sugar) test performed by hand-held instrument
|
97 | 77 | $13.00 | $3.21 |
|
G0438
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit
|
40 | 40 | $225.00 | $158.98 |
|
93000
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report
|
39 | 38 | $50.00 | $13.78 |
|
G0402
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment
|
34 | 34 | $220.74 | $159.54 |
|
99496
Transitional care management services for problem of high complexity
|
30 | 28 | $300.00 | $270.46 |
|
99205
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
|
19 | 19 | $374.00 | $212.47 |
|
90661
Influenza vaccine, trivalent derived from cell cultures
|
15 | 15 | $54.00 | $36.11 |
|
77080
Dxa bone density measurement of hip, pelvis, spine
|
12 | 12 | $85.00 | $37.21 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 893 | 74,200 | $9,962.61 | 236 |
| Levothyroxine Sodium | Levothyroxine Sodium | 660 | 54,882 | $7,160.29 | 165 |
| Atorvastatin Calcium | Atorvastatin Calcium | 560 | 48,520 | $5,162.74 | 149 |
| Amlodipine Besylate | Amlodipine Besylate | 501 | 40,083 | $2,966.81 | 142 |
| Lisinopril | Lisinopril | 394 | 32,727 | $2,288.55 | 106 |
| Carvedilol | Carvedilol | 341 | 28,031 | $2,368.95 | 92 |
| Losartan Potassium | Losartan Potassium | 311 | 27,538 | $2,804.15 | 88 |
| Metformin Hcl Er | Metformin Hcl | 272 | 21,960 | $2,304.23 | 72 |
| Escitalopram Oxalate | Escitalopram Oxalate | 270 | 17,336 | $3,196.33 | 72 |
| Valsartan | Valsartan | 264 | 19,538 | $5,879.16 | 69 |
| Omeprazole | Omeprazole | 259 | 21,587 | $3,211.63 | 70 |
| Ozempic | Semaglutide | 255 | 13,031 | $411,988.07 | 50 |
| Jardiance | Empagliflozin | 242 | 16,000 | $297,433.67 | 52 |
| Glimepiride | Glimepiride | 232 | 19,860 | $1,923.67 | 68 |
| Gabapentin | Gabapentin | 220 | 13,487 | $3,171.96 | 56 |
| Trazodone Hcl | Trazodone Hcl | 211 | 14,779 | $1,496.01 | 61 |
| Montelukast Sodium | Montelukast Sodium | 205 | 16,743 | $2,366.00 | 61 |
| Duloxetine Hcl | Duloxetine Hcl | 199 | 13,692 | $4,496.27 | 50 |
| Ezetimibe | Ezetimibe | 195 | 14,958 | $4,423.28 | 55 |
| Meloxicam | Meloxicam | 191 | 10,500 | $580.86 | 42 |
| Hydrochlorothiazide | Hydrochlorothiazide | 186 | 16,662 | $724.82 | 59 |
| Metoprolol Succinate | Metoprolol Succinate | 184 | 15,895 | $2,940.40 | 56 |
| Pravastatin Sodium | Pravastatin Sodium | 173 | 14,695 | $1,987.77 | 51 |
| Synthroid | Levothyroxine Sodium | 169 | 14,130 | $8,572.58 | 45 |
| Simvastatin | Simvastatin | 164 | 14,670 | $2,119.71 | 49 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-08-13NUCC Taxonomy Code: 207RE0101X
An internist who concentrates on disorders of the internal (endocrine) glands such as the thyroid and adrenal glands. This specialist also deals with disorders such as diabetes, metabolic and nutritional disorders, obesity, pituitary diseases and menstrual and sexual problems.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - INTERNAL MEDICINE
I20040623000029
VA
0244215622
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Professional Therapies Of Roanoke, Inc.
6800 Woodlake Commons Loop, Midlothian, VA 231122281
Phone: 8043024589
Virginia Diabetes And Endocrinology Pc
348 Browns Hill Ct, Midlothian, VA 231149511
Phone: 8042722702
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine
Doctor of Medicine (M.D.)
Internal Medicine - Endocrinology, Diabetes & Metabolism
Doctor of Medicine (M.D.)
Internal Medicine - Endocrinology, Diabetes & Metabolism
Doctor of Medicine (M.D.)
Internal Medicine - Endocrinology, Diabetes & Metabolism
Doctor of Medicine (M.D.)
Internal Medicine
Doctor of Medicine (M.D.)
Internal Medicine - Endocrinology, Diabetes & Metabolism
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 348 BROWNS HILL CT, MIDLOTHIAN, VA 231149511 (Tel: 8042722702)
Internal Medicine (license number reported to NPPES: VA 0101042848)
NPI status registered as active in NPPES database
Registered at 348 BROWN'S HILL CT, MIDLOTHIAN, VA 23114 (Tel: 8042722702)
Registered at 348 BROWNS HILL CT, MIDLOTHIAN, VA 23114 (Tel: 8042722702)
Recorded as STEPHEN YOUNG, M.D.
Internal Medicine (license number reported to NPPES: VA 0101042848)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine - Endocrinology, Diabetes & Metabolisms in Midlothian
- Dr. Cynthia Ryan, MD
- Dr. Lauren Lamb, MD
- Dr. Meredith Berger, MD
- Dr. Helen Kuno, MD
- Dr. Alexander Millis, MD
- Dr. Ben Phillips, MD
Mailing Address
348 Browns Hill Ct
Midlothian, VA 231149511
Phone: 8042722702